Antivirus Therapeutics, Inc. — Form D
Antivirus Therapeutics, Inc. of PRINCETON JCT., NJ, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-01. The offering totals $5.0M, of which $743K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-01
- Form: D
- Accession: 0001588163-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $743K
- Remaining: $4.3M
- Investors: 2
- Date of first sale: 2013-09-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-203821
Issuer
- Name: Antivirus Therapeutics, Inc.
- CIK: 0001588163
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 7 ARDSLEY CT., PRINCETON JCT., NJ, 08550
- Phone: 609-240-2517
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Anand Gumaste | Director | PRINCETON JCT., NJ |
| Anand Gumaste | Executive Officer | PRINCETON JCT., NJ |
More